These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33607326)
1. Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of Fiaccabrino DE; Kunz P; Radchenko V Nucl Med Biol; 2021; 94-95():81-91. PubMed ID: 33607326 [TBL] [Abstract][Full Text] [Related]
2. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119. Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758 [TBL] [Abstract][Full Text] [Related]
3. Development of implantation substrates for the collection of radionuclides of medical interest produced via ISOL technique at INFN-LNL. Ballan M; Vettorato E; Morselli L; Tosato M; Nardella S; Borgna F; Corradetti S; Monetti A; Lunardon M; Zenoni A; Di Marco V; Realdon N; Andrighetto A Appl Radiat Isot; 2021 Sep; 175():109795. PubMed ID: 34087532 [TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of MC1R targeting theranostic pair [ Wharton L; McNeil SW; Zhang C; Engudar G; Van de Voorde M; Zeisler J; Koniar H; Sekar S; Yuan Z; Schaffer P; Radchenko V; Ooms M; Kunz P; Bénard F; Yang H Nucl Med Biol; 2024; 136-137():108925. PubMed ID: 38796924 [TBL] [Abstract][Full Text] [Related]
5. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application. Müller C; Domnanich KA; Umbricht CA; van der Meulen NP Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792 [TBL] [Abstract][Full Text] [Related]
6. Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations. Filosofov D; Kurakina E; Radchenko V Nucl Med Biol; 2021; 94-95():1-19. PubMed ID: 33461040 [TBL] [Abstract][Full Text] [Related]
7. The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy. Lehenberger S; Barkhausen C; Cohrs S; Fischer E; Grünberg J; Hohn A; Köster U; Schibli R; Türler A; Zhernosekov K Nucl Med Biol; 2011 Aug; 38(6):917-24. PubMed ID: 21843788 [TBL] [Abstract][Full Text] [Related]
8. Production of Copper Radionuclides in Compact Medical Cyclotrons using Solid Targets. Avila-Rodriguez MA; Valdovinos HF Curr Radiopharm; 2021; 14(4):340-353. PubMed ID: 32981514 [TBL] [Abstract][Full Text] [Related]
9. New method for production of Moiseeva AN; Aliev RA; Furkina EB; Novikov VI; Unezhev VN Nucl Med Biol; 2022; 106-107():52-61. PubMed ID: 35032789 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Radiometals Beyond Müller C; van der Meulen NP; Benešová M; Schibli R J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619 [TBL] [Abstract][Full Text] [Related]
11. Theranostic Terbium Radioisotopes: Challenges in Production for Clinical Application. Naskar N; Lahiri S Front Med (Lausanne); 2021; 8():675014. PubMed ID: 34136508 [TBL] [Abstract][Full Text] [Related]
12. Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside. Van Laere C; Koole M; Deroose CM; de Voorde MV; Baete K; Cocolios TE; Duchemin C; Ooms M; Cleeren F Theranostics; 2024; 14(4):1720-1743. PubMed ID: 38389843 [TBL] [Abstract][Full Text] [Related]
13. Co-production of Moiseeva AN; Makoveeva KA; Furkina EB; Artyushova EV; German MN; Khomenko IA; Konevega AL; Kormazeva ES; Novikov VI; Aksenov NV; Gustova NS; Aliev RA Nucl Med Biol; 2023; 126-127():108389. PubMed ID: 37783103 [TBL] [Abstract][Full Text] [Related]
14. Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with Kostelnik TI; Olson AP; Grundmane A; Ellison PA; Mynerich J; Chen S; Marinova A; Randhawa P; Karaivanov D; Aluicio-Sarduy E; Barnhart TE; Orvig C; Ramogida CF; Hoehr C; Filosofov D; Engle JW; Radchenko V Nucl Med Biol; 2023; 122-123():108352. PubMed ID: 37390607 [TBL] [Abstract][Full Text] [Related]
15. Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598 [TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with Baum RP; Singh A; Benešová M; Vermeulen C; Gnesin S; Köster U; Johnston K; Müller D; Senftleben S; Kulkarni HR; Türler A; Schibli R; Prior JO; van der Meulen NP; Müller C Dalton Trans; 2017 Oct; 46(42):14638-14646. PubMed ID: 28825750 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced Ramogida CF; Robertson AKH; Jermilova U; Zhang C; Yang H; Kunz P; Lassen J; Bratanovic I; Brown V; Southcott L; Rodríguez-Rodríguez C; Radchenko V; Bénard F; Orvig C; Schaffer P EJNMMI Radiopharm Chem; 2019 Aug; 4(1):21. PubMed ID: 31659557 [TBL] [Abstract][Full Text] [Related]
18. Cross section measurement of terbium radioisotopes for an optimized Dellepiane G; Casolaro P; Favaretto C; Grundler PV; Mateu I; Scampoli P; Talip Z; van der Meulen NP; Braccini S Appl Radiat Isot; 2022 Jun; 184():110175. PubMed ID: 35344829 [No Abstract] [Full Text] [Related]
19. Deuteron induced Tb-155 production, a theranostic isotope for SPECT imaging and auger therapy. Duchemin C; Guertin A; Haddad F; Michel N; Métivier V Appl Radiat Isot; 2016 Dec; 118():281-289. PubMed ID: 27723559 [TBL] [Abstract][Full Text] [Related]
20. Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice. Müller C; Fischer E; Behe M; Köster U; Dorrer H; Reber J; Haller S; Cohrs S; Blanc A; Grünberg J; Bunka M; Zhernosekov K; van der Meulen N; Johnston K; Türler A; Schibli R Nucl Med Biol; 2014 May; 41 Suppl():e58-65. PubMed ID: 24360901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]